Table 3.
Characteristics of patients with hepatocellular carcinoma who underwent hepatic resection
| High LMR (n = 187) | Low LMR (n = 94) | P | |
|---|---|---|---|
| Age (years)* | 68 (31–87) | 69 (28–85) | 0·741 |
| Sex ratio (M : F) | 148 : 39 | 76 : 18 | 0·737 |
| BMI (kg/m2)* | 22·7 (15·7–32·1) | 23·0 (14·2–30·9) | 0·126 |
| HBsAg+ | 38 (20·3) | 16 (17) | 0·507 |
| HCV‐Ab+ | 105 (56·1) | 58 (62) | 0·373 |
| Diabetes mellitus | 55 (29·4) | 26 (28) | 0·759 |
| Child–Pugh grade | 0·553 | ||
| A | 184 (98·4) | 94 (100) | |
| B | 3 (1·6) | 0 (0) | |
| Oesophageal varix | 12 (6·4) | 7 (7·4) | 0·745 |
| Total bilirubin (mg/dl)* | 0·7 (0·3–2·6) | 0·7 (0·2–1·5) | 0·537 |
| Albumin (g/dl)* | 4·1 (2·8–5·3) | 3·9 (1·8–4·8) | < 0·001 |
| Prothrombin time (%)* | 89 (63–116) | 96 (65–116) | 0·036 |
| ICGR15 (%)* | 13 (1·6–43·1) | 11·5 (3·0–34·6) | 0·454 |
| AFP (ng/ml)* | 7·6 (0·5–170 668) | 18·2 (1·6–994 600) | < 0·001 |
| DCP (munits/ml)* | 73 (9–75 000) | 111 (2–75 000) | 0·115 |
| Tumour size (cm)* | 3·2 (0·9–13·0) | 4·0 (1·2–16·5) | < 0·001 |
| No. of tumours | |||
| 1 | 155 (82·9) | 75 (80) | 0·524 |
| ≥ 2 | 32 (17·1) | 19 (20) | |
| Poor differentiation | 47 (25·1) | 35 (37) | 0·035 |
| Microvascular invasion | 59 (31·6) | 37 (39) | 0·192 |
| Microscopic intrahepatic metastases | 27 (14·4) | 16 (17) | 0·570 |
| Liver cirrhosis | 31 (16·6) | 29 (31) | 0·008 |
| Duration of surgery (min)* | 325 (117–759) | 321 (147–770) | 0·389 |
| Blood loss (ml)* | 500 (0–13 000) | 568 (5–5723) | 0·229 |
| Blood transfusion | 16 (8·6) | 13 (14) | 0·170 |
Values in parentheses are percentages unless indicated otherwise;
*
values are median (range). LMR, lymphocyte‐to‐monocyte ratio; HBsAg, hepatitis B surface antigen; HCV‐Ab, hepatitis C virus antibody; ICGR15, indocyanine green retention rate at 15 min; AFP, α‐fetoprotein; DCP, des‐γ‐carboxyprothrombin.